Utah Medical Products (UTMD): Company Short-Term Debts

Public company logo of Utah Med (UTMD)

Utah Medical Products (UTMD) produces high-tech diagnostic and therapeutic devices, as illustrated by this price action of the securities. The current indicator is 0.00. The company's revenues are based on the demand for products in neonatology and gynecology, where brand image and certification are critical. Consumables integrated into clinics ensure business stability, although expansion is limited by strict FDA control.

UTMD (Utah Medical Products, Inc.) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

Analytical breakdowns for Utah Med (UTMD)

- stock price and consensus target price:
Stock Price Utah Medical Products, Inc.|UTMD - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Utah Medical Products, Inc.|UTMD - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share Utah Medical Products|UTMD - Book Capitalization|Market Value to Book Value Ratio utahmed.com|UTMD - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Utah Medical Products|UTMD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Utah Medical Products|UTMD - Company Total Debt Obligations|Debt to Book Capitalization Ratio Utah Medical Products, Inc.|UTMD - Company Long-Term Indebtedness|Company Short-Term Debt Utah Medical Products|Quick Liquidity Indicator utahmed.com
- net income and valuation multiples indicators:
UTMD - Profit After Payment of Taxes
Fundamental company analysis:UTMD - Utah Medical Products, Inc.
Flagship merchandise of Utah Med

Utah Medical Products maintains a conservative approach, prioritizing organic growth and liquidity preservation. Analyzing the short-term debt load, an investor can see the volume of obligations due within the coming year. This metric measures the current financial burden, revealing the business's reliance on external loans. Minimal values confirm a strategy of avoiding leveraged capital. Such a liability structure guarantees high capital stability for the company.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ZIMV|Company Short-Term Debt AngioDynamics ANGO|Company Short-Term Loans and Borrowings CERS|TKNO: Company Current Liabilities|MGRM - Company Short-Term Debts|sharpstechnology.com (STSS) - Company Short-Term Debt|Company Current Liabilities InfuSystem Holdings, Inc.|KRMD (KORU Medical Systems, Inc.) - Company Short-Term Debts|Short-Term Debt Nyxoah SA NYXH|Company Short-Term Debt Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Company Short-Term Indebtedness|Zentek Ltd. - Company Current Liabilities|Amount of Current Liabilities ELUT (elutia.com)|MLSS - Company Short-Term Debt|Short-Term Debt Volume NEXGEL Inc. NXGL|RVP (retractable.com) - Company Current Liabilities|Harvard Bioscience Inc. (HBIO) - Company Short-Term Debts|Company Current Liabilities FEMY|MHUA (Meihua Medical) - Amount of Current Liabilities|Company Short-Term Debts POAI|Company Short-Term Debts callanjmb.com (CJMB)|Company Short-Term Debts ATRI (Atrion Corp)|Company Short-Term Loans and Borrowings NURO